Klinische Forschung Hamburg GmbH
About Klinische Forschung Hamburg GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
12
Kowa Research Europe
4
Idorsia Pharmaceuticals Ltd.
2
UNION therapeutics
2
Allergan
1
AnaptysBio, Inc.
1
Bayer
1
Bristol-Myers Squibb
1
Eli Lilly and Company
1
Integrative Research Laboratories AB
1
Janssen Vaccines & Prevention B.V.
1
Clinical Trials at Klinische Forschung Hamburg GmbH
During the past decade, Klinische Forschung Hamburg GmbH conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 14 clinical trials were completed, i.e. on
average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 10 clinical trials were completed. i.e. 90.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
2005-10-01
2006-11-01
Completed
830
Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients
2005-09-01
2006-05-01
Completed
962
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-07-01
2007-11-01
Completed
1,355
Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-06-01
2007-12-01
Completed
545
Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip
2009-08-11
2010-11-24
Terminated
607
Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma
2010-06-01
2011-05-01
Completed
344
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
2010-09-01
2016-06-01
Terminated
2,867
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinische Forschung Hamburg GmbH" #1 sponsor was "Pfizer" with 12 trials, followed by "Kowa Research Europe" with 4 trials
sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored, "UNION therapeutics" with 2 trials sponsored and "Allergan"
with 2 trials sponsored. Other sponsors include 9 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinische Forschung Hamburg GmbH"
#1 collaborator was "Biofortis Mérieux NutriSciences" with 1 trials as a collaborator, "FGK Clinical Research GmbH" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Labor Dr. Spranger (Central lab)" with 1 trials as a collaborator and "Laboratorios LETI SL (Study Medication)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Klinische Forschung Hamburg GmbH
According to Clinical.Site data, the most researched conditions in "Klinische Forschung Hamburg GmbH" are
"Psoriasis" (5 trials), "Smoking Cessation" (4 trials), "Dermatitis, Atopic" (3 trials), "Depressive Disorder, Major" (2 trials) and "Dyslipidemia" (2 trials). Many other conditions were trialed in "Klinische Forschung Hamburg GmbH" in a lesser frequency.
Clinical Trials Intervention Types at Klinische Forschung Hamburg GmbH
Most popular intervention types in "Klinische Forschung Hamburg GmbH" are "Drug" (30 trials), "Biological" (7 trials), "Other" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (17 trials), "Pitavastatin" (4 trials), "placebo" (3 trials), "CP-690,550" (2 trials) and "Daridorexant 25 mg" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Klinische Forschung Hamburg GmbH
The vast majority of trials in "Klinische Forschung Hamburg GmbH" are
35 trials for "All" genders.
Clinical Trials Status at Klinische Forschung Hamburg GmbH
Currently, there are NaN active trials in "Klinische Forschung Hamburg GmbH".
undefined are not yet recruiting,
4 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Klinische Forschung Hamburg GmbH,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Klinische Forschung Hamburg GmbH, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 23 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 1 trials that are defined as “Not Applicable".